Myriad Genetics, Inc.

Myriad Genetics, Inc. is a leading molecular diagnostic company focused on developing and marketing novel predictive medicine, personalized medicine, and prognostic medicine products that prevent or mitigate serious diseases such as cancer. We began working with them during 2011 after winning the assignment for the reintroduction of OnDose, a test used in the treatment of colon cancer.